Mealey's (January 16, 2019, 1:53 PM EST) -- WASHINGTON, D.C. — Attorneys for the United States on Jan. 14 filed a brief in the District of Columbia Circuit U.S. Court of Appeals arguing that a lower court erred when it ruled that defendants in a qui tam lawsuit over the exposure risk associated with isocyanate chemicals had no obligation to transmit or deliver substantial risk information (SRI) to the U.S. government (United States ex rel. Kasowitz Benson Torres LLP v. BAS Corporation, et al., No. 18-7123, D.C. Cir.)....